Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Outpatient & Requisition Cultures
Gram Positive Organisms, Community Non-Urine Isolates Only, All Ages
Antibiogram susceptibility of frequently encountered Gram-positive aerobic bacteria recovered from community specimens (excluding urines) submitted to the University of North Carolina Hospitals Microbiology Laboratory
between 4/22/2016 and 12/31/2017 for all staphylococcal and other Gram-positive isolates. These data are based on computer analysis of isolates not defined as healthcare associated: community isolates are defined as
those collected in an outpatient setting. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for
the balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not
be a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
PIC
ILL
IN
CL
IND
AM
YC
IN
DA
PT
OM
YC
IN
DO
XY
CY
CL
INE
ER
YT
HR
OM
YC
IN
GE
NT
AM
ICIN
LIN
EZ
OL
ID
OX
AC
ILL
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S S S
Coagulase negative Staphylococcus species 11 64 91 45 100 100 64 91 100
Enterococcus faecalis 44 100 50 100 91
Methicillin resistant Staphylococcus aureus 825 62 88 90 12 98 100 0 96 100
Methicillin-Susceptible Staphylococcus aureus 1,632 71 94 56 98 100 100 98 100
Staphylococcus epidermidis 12 75 92 58 83 100 58 58 100
Staphylococcus lugdunensis 242 77 91 71 99 100 93 94 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (10 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Outpatient & Requisition Cultures
Gram Negative Organisms, Community Non-Urine Isolates Only, All Ages
Antimicrobial susceptibility of frequently encountered Gram-negative aerobic bacteria recovered from community specimens (excluding urines) submitted to the University of North Carolina Hospitals Microbiology
Laboratory between 4/22/2016 and12/31/2017 . These data are based on computer analysis of isolates not defined as healthcare associated: community isolates are defined as those collected in an outpatient setting.
Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are
included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to
have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY T
OT
AL
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
ER
TA
PE
NE
M
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
ME
RO
PE
NE
M
MIN
OC
YC
LIN
E
PIP
ER
AC
ILL
IN +
TA
ZO
BA
CT
AM
TO
BR
AM
YC
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
S S S S S S S S S S S S S S S S
Acinetobacter baumannii complex 14 86 64 57 64 57 79 64 79 43 86
Enterobacter cloacae/ asburiae group 27 100 92 81 50 85 96 96 100 85 93
Escherichia coli 47 98 17 53 23 66 64 100 81 47 100 98 83
Klebsiella pneumoniae 22 86 73 64 82 82 95 91 82 95 73 82
Proteus mirabilis 23 100 83 91 9 100 100 100 100 91 91 100 100 96
Pseudomonas aeruginosa 513 89 93 93 83 85 75 91 92 95
Serratia marcescens 49 100 100 100 100 100 98 98 100 94
Stenotrophomonas maltophilia 88 27 74 100 82
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (10 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Outpatient & Requisition Cultures
Gram Positive Organisms, Community Urine Isolates, All Ages
Antimicrobial susceptibility of frequently encountered Gram-positive aerobic bacteria recovered from patient urine specimens submitted to the University of North Carolina Hospitals Microbiology Laboratory
between4/22/2016 and 12/31/2017 for all isolates. These data are based on computer analysis of isolates not defined as healthcare associated: community isolates are defined as those collected in an outpatient setting.
Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are
included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to
have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY T
OT
AL
AM
PIC
ILL
IN
DO
XY
CY
CL
INE
GE
NT
AM
ICIN
LIN
EZ
OL
ID
NIT
RO
FU
RA
NT
OIN
OX
AC
ILL
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S
Coagulase negative Staphylococcus species 262 88 85 100 98 42 48 100
Enterococcus faecalis 581 100 31 96 99 99
Enterococcus faecium 31 19 23 100 58
Methicillin resistant Staphylococcus aureus 52 94 100 100 100 90 100
Methicillin-Susceptible Staphylococcus aureus 75 97 100 100 99 100 100 100
Staphylococcus lugdunensis 33 94 97 100 100 97 90 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (10 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Outpatient & Requisition Cultures
Gram Negative Organisms, Community Urine Isolates, All Ages
Antimicrobial susceptibility of frequently encountered Gram-negative aerobic bacteria recovered from patient urine specimens submitted to the University of North Carolina Hospitals Microbiology Laboratory between 4/22/2016 and 12/31/2017
for all isolates. These data are based on computer analysis of isolates not defined as healthcare associated: community isolates are defined as those collected in an outpatient setting. Results are expressed as percent of strains tested to be
susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In
cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FA
ZO
LIN
(O
RA
L P
RE
DIC
TO
R)
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
ER
TA
PE
NE
M
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
ME
RO
PE
NE
M
NIT
RO
FU
RA
NT
OIN
PIP
ER
AC
ILL
IN +
TA
ZO
BA
CT
AM
TO
BR
AM
YC
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
S S S S S S S S S S S S S S S S S
Citrobacter freundii 40 85 83 98 90 82 98 100 95 77
Citrobacter koseri 72 92 90 99 99 100 99 99 100 96 99 97
Citrobacter species 97 84 94 99 97 95 100 89 96 88
Enterobacter cloacae/ asburiae group 121 78 88 90 97 91 98 58 96 78
Escherichia coli 4,939 51 80 58 90 93 75 100 92 77 100 97 92 72
Klebsiella (Enterobacter) aerogenes 117 100 85 96 98 100 98 100 30 100 96
Klebsiella oxytoca 96 88 11 99 95 99 97 97 100 93 97 91
Klebsiella pneumoniae 1,101 87 79 96 96 92 99 97 96 100 48 97 81
Proteus mirabilis 367 89 96 7 95 100 87 100 96 89 100 97 84
Pseudomonas aeruginosa 192 93 93 94 78 86 73 89 90 96
Serratia marcescens 75 97 96 100 99 96 100 95 96
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (35 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 5/1/2018 at 0255
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Emergency Dept - Non-Urines
Antimicrobial susceptibility of frequently encountered aerobic bacteria recovered from Inpatient specimens (excluding urines) collected in the emergency department and submitted to the UNC Microbiology Laboratory
between 4/22/2016 and 12/31/2017. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for
the balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may
not be a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CL
IND
AM
YC
IN
DA
PT
OM
YC
IN
DO
XY
CY
CL
INE
ER
TA
PE
NE
M
ER
YT
HR
OM
YC
IN
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
LIN
EZ
OL
ID
ME
RO
PE
NE
M
OX
AC
ILL
IN
PIP
ER
AC
ILL
IN +
TA
ZO
BA
CT
AM
TO
BR
AM
YC
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S S S S S S S S S S S S S S
Enterococcus faecalis 57 100 100 100 96
Escherichia coli 194 98 42 72 44 83 83 99 90 66 99 94 84 100
Klebsiella pneumoniae 77 100 87 71 100 100 96 99 95 93 99 92 96
Methicillin resistant Staphylococcus aureus 381 80 88 93 14 98 100 0 97 100
Methicillin-Susceptible Staphylococcus aureus 433 83 96 62 100 100 100 100 100
Pseudomonas aeruginosa 85 91 96 98 88 83 92 96 95
Staphylococcus epidermidis 59 55 100 81 29 75 100 32 46 100
Staphylococcus lugdunensis 78 79 95 74 99 100 91 95 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (35 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0321
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Collection Department, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Emergency Dept - Urines
Antimicrobial susceptibility of frequently encountered aerobic bacteria recovered from Inpatient urine specimens collected in the emergency department and submitted to the UNC Microbiology Laboratory between
4/22/2016 and 12/31/2017. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the
balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be
a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FA
ZO
LIN
(O
RA
L P
RE
DIC
TO
R)
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
DO
XY
CY
CL
INE
ER
TA
PE
NE
M
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
LIN
EZ
OL
ID
ME
RO
PE
NE
M
NIT
RO
FU
RA
NT
OIN
OX
AC
ILL
IN
TO
BR
AM
YC
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S S S S S S S S S S S S
Coagulase negative Staphylococcus species 46 93 83 100 100 57 50
Enterobacter cloacae/ asburiae group 31 81 94 90 100 94 100 65 97 90
Enterococcus faecalis 117 99 15 95 98 98
Escherichia coli 1,284 100 49 78 59 90 92 79 100 93 80 100 97 93 73
Klebsiella (Enterobacter) aerogenes 28 96 100 100 100 100 100 14 100 100
Klebsiella oxytoca 27 74 4 96 93 100 88 93 100 100 93 81
Klebsiella pneumoniae 219 87 82 95 96 94 100 97 96 100 53 97 86
Proteus mirabilis 71 92 96 7 96 99 83 100 94 82 100 94 83
Pseudomonas aeruginosa 60 95 93 95 68 93 65 83 97
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (20 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0321
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Collection Department, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Positive Organisms, Inpatient Non-ICU , Non-Urine Isolates, Adult Only
Antimicrobial susceptibility of frequently encountered Gram-positive aerobic bacteria recovered from inpatient specimens (excluding urines) submitted to the University of North Carolina Hospitals Microbiology Laboratory
between 4/22/2016 and 12/31/2017 for staphylococcal isolates and all other Gram positive isolates. These data are based on computer analysis of isolates defined as healthcare associated; i.e. those collected in an
inpatient setting; excluding samples from the ICU. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains
account for the balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of
isolates may not be a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
PIC
ILL
IN
CL
IND
AM
YC
IN
DA
PT
OM
YC
IN
DO
XY
CY
CL
INE
ER
YT
HR
OM
YC
IN
GE
NT
AM
ICIN
LIN
EZ
OL
ID
OX
AC
ILL
IN
RIF
AM
PIN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S S S S
Coagulase negative Staphylococcus species 52 50 100 79 36 79 100 37 100 58 100
Enterococcus faecalis 120 100 100 30 97 98
Enterococcus faecium 73 11 92 67 100 14
Methicillin resistant Staphylococcus aureus 585 67 88 91 12 97 100 98 95 100
Methicillin-Susceptible Staphylococcus aureus 720 78 100 95 65 99 100 100 100 98 100
Staphylococcus epidermidis 84 43 63 78 25 65 99 25 95 36 97
Staphylococcus lugdunensis 108 67 94 63 100 100 87 100 98 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (30 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Negative Organisms, Inpatient Non-ICU, Non-Urine Isolates, Adult Only
Antimicrobial susceptibility of frequently encountered Gram-negative aerobic bacteria recovered from Inpatient (excluding ICU) specimens (excluding urines) submitted to the University of North Carolina Hospitals Microbiology Laboratory between
4/22/2016 and 12/31/2017. These data are based on computer analysis of isolates defined as nosocomial; i.e. those collected in an inpatient setting; excluding samples from the ICU. Results are expressed as percent of strains tested to be
susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases
where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
ER
TA
PE
NE
M
LE
VO
FL
OX
AC
IN
ME
RO
PE
NE
M
MIN
OC
YC
LIN
E
PIP
ER
AC
ILL
IN +
TA
ZO
BA
CT
AM
TO
BR
AM
YC
IN
S S S S S S S S S S S S S S
Acinetobacter baumannii complex 21 86 90 71 67 75 85 81 100 53 86
Enterobacter cloacae/ asburiae group 61 98 80 100 75 100 85 92 95 80 95
Escherichia coli 233 97 33 59 37 82 100 81 36 100 56 100 90 85
Klebsiella (Enterobacter) aerogenes 32 94 84 72 91 94 97 66 97
Klebsiella oxytoca 20 100 84 11 100 100 100 100 95 100 95 100
Klebsiella pneumoniae 92 99 78 74 87 67 85 50 98 84 99 91 87
Proteus mirabilis 39 100 87 97 11 91 100 92 83 100 89 100 97 100
Pseudomonas aeruginosa 370 90 88 88 79 72 86 84 96
Serratia marcescens 71 99 99 100 96 97 92 97 100 87
Stenotrophomonas maltophilia 57 40 84 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (20 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 5/1/2018 at 0258
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Positive Organisms, Inpatient Non-ICU Urine Isolates, Adult Only
Antimicrobial susceptibility of frequently encountered Gram-positive aerobic bacteria recovered from patient urine specimens submitted to the University of North Carolina Hospitals Microbiology Laboratory between
4/22/2016 and 12/31/2017. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the
balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be
a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
PIC
ILL
IN
DO
XY
CY
CL
INE
GE
NTA
MIC
IN
LIN
EZ
OL
ID
NIT
RO
FU
RA
NT
OIN
OX
AC
ILL
IN
TR
IME
TH
OP
RIM
+
SU
LFA
ME
TH
OX
AZ
OL
EV
AN
CO
MY
CIN
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S
Coagulase negative Staphylococcus species 55 75 67 100 100 35 35 100
Enterococcus faecalis 227 100 30 93 99 99
Enterococcus faecium 60 3 20 95 5 20
Methicillin resistant Staphylococcus aureus 29 86 100 100 100 93 100
Methicillin-Susceptible Staphylococcus aureus 26 88 100 100 100 100 100 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (25 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 5/8/2018 at 1000
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Negative Organisms, Inpatient Non-ICU Urine Isolates, Adult Only
Antimicrobial susceptibility of frequently encountered Gram-negative aerobic bacteria recovered from patient urine specimens submitted to the University of North Carolina Hospitals Microbiology Laboratory between
4/22/2016 and 12/31/2017. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the
balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be
a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FA
ZO
LIN
(O
RA
L P
RE
DIC
TO
R)
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
ER
TA
PE
NE
M
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
ME
RO
PE
NE
M
NIT
RO
FU
RA
NT
OIN
TO
BR
AM
YC
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
S S S S S S S S S S S S S S S S
Citrobacter koseri 30 90 90 100 100 100 100 100 100 93 100 93
Citrobacter species 21 71 90 100 90 95 100 90 95 86
Enterobacter cloacae/ asburiae group 46 67 83 87 100 87 96 48 100 89
Escherichia coli 1,204 100 46 75 52 86 89 72 100 93 73 100 97 92 71
Klebsiella (Enterobacter) aerogenes 34 76 94 100 100 94 100 21 100 100
Klebsiella oxytoca 32 84 3 91 94 97 94 94 97 94 97 91
Klebsiella pneumoniae 278 78 71 89 91 88 99 92 92 99 49 92 80
Proteus mirabilis 101 82 94 6 93 97 83 100 90 85 100 92 70
Pseudomonas aeruginosa 119 94 87 87 79 87 69 79 97
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (20 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Positive Organisms, ICU Non-Urine Isolates, Adult Only
Antimicrobial susceptibility of frequently encountered aerobic Gram-positive bacteria recovered from Adult ICU* (excluding Burn ICU) specimens (excluding urines) submitted to the University of North Carolina Hospitals
Microbiology Laboratory between 4/22/2016 and 12/31/2017 for staphylococcal isolates and other Gram positive isolates. These data are based on computer analysis of isolates defined as healthcare associated; i.e.
those collected in an inpatient ICU setting. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account
for the balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates
may not be a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
PIC
ILL
IN
CL
IND
AM
YC
IN
DA
PT
OM
YC
IN
DO
XY
CY
CL
INE
GE
NT
AM
ICIN
LIN
EZ
OL
ID
OX
AC
ILL
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S S
Enterococcus faecalis 27 100 100 100 96
Enterococcus faecium 25 6 100 100 4
Methicillin resistant Staphylococcus aureus 105 58 100 94 96 100 96 100
Methicillin-Susceptible Staphylococcus aureus 114 77 100 94 100 99 100 99 99
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (20 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Collection Department, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Negative Organisms, ICU Non-Urine Isolates, Adults Only
Antimicrobial susceptibility of frequently encountered Gram-negative aerobic bacteria recovered from Adult ICU specimens (excluding urines) and excluding the Burn ICU submitted to the University of North Carolina
Hospitals Microbiology Laboratory between 4/22/2016 and 12/31/2017. These data are based on computer analysis of isolates defined as healthcare associated; i.e. those collected in an inpatient ICU setting. Results are
expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are included only if
more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to have statistical
validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY T
OT
AL
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
ER
TA
PE
NE
M
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
ME
RO
PE
NE
M
MIN
OC
YC
LIN
E
PIP
ER
AC
ILL
IN +
TA
ZO
BA
CT
AM
TO
BR
AM
YC
IN
S S S S S S S S S S S S S S S
Enterobacter cloacae/ asburiae group 25 100 72 64 84 92 84 84 64 88
Escherichia coli 49 92 31 52 31 77 100 76 100 84 60 100 85 82
Klebsiella (Enterobacter) aerogenes 18 89 94 72 100 100 94 100 61 100
Klebsiella pneumoniae 45 96 73 64 87 100 87 93 89 84 93 77 89
Pseudomonas aeruginosa 87 91 83 84 83 84 77 76 82 99
Serratia marcescens 20 100 100 100 100 100 100 95 100 90
Stenotrophomonas maltophilia 48 26 90 98
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (20 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Collection Department, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
ICU Urine Isolates, Adult Only
Antimicrobial susceptibility of frequently encountered aerobic bacteria recovered from Adult ICU urine specimens (excluding Burn ICU)* submitted to the University of North Carolina Hospitals Microbiology Laboratory
between 4/22/2016 and 12/31/2017. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for
the balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may
not be a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FA
ZO
LIN
(O
RA
L P
RE
DIC
TO
R)
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
DO
XY
CY
CL
INE
ER
TA
PE
NE
M
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
LIN
EZ
OL
ID
ME
RO
PE
NE
M
NIT
RO
FU
RA
NT
OIN
TO
BR
AM
YC
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S S S S S S S S S S S
Enterobacter cloacae/ asburiae group 11 82 91 91 100 100 91 73 100 100
Enterococcus faecalis 45 98 27 84 100 100
Enterococcus faecium 12 8 33 92 17 33
Escherichia coli 96 30 66 39 75 83 56 100 84 57 100 95 86 71
Klebsiella pneumoniae 35 80 71 86 86 80 94 91 88 94 49 89 80
Proteus mirabilis 15 80 93 7 100 100 73 100 80 73 100 80 60
Pseudomonas aeruginosa 26 92 92 96 85 88 76 85 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (10 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0321
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Collection Department, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Positive Organisms, Pediatric Inpatient Isolates Only, Non-Urine
Antimicrobial susceptibility of frequently encountered Gram-positive aerobic bacteria recovered from pediatric inpatient unit specimens (excluding urines and respiratory specimens from Cystic Fibrosis patients) submitted
to the University of North Carolina Health Care Microbiology Laboratory between 4/22/2016 and 12/31/2017 for staphylococcal isolates and all other Gram positive isolates. Results are expressed as percent of strains
tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are included only if more than 30 isolates were
tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to have statistical validity.
UNCH MCLENDON LABORATORY
TO
TA
L
AM
PIC
ILL
IN
CL
IND
AM
YC
IN
DO
XY
CY
CL
INE
GE
NT
AM
ICIN
LIN
EZ
OL
ID
OX
AC
ILL
IN
RIF
AM
PIN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN
VA
NC
OM
YC
IN S
CR
EE
N
S S S S S S S S S S
Enterococcus faecalis 16 100 67 100
Methicillin resistant Staphylococcus aureus 52 75 94 100 100 96 98 100
Methicillin-Susceptible Staphylococcus aureus 71 77 97 97 100 100 100 100 100
Staphylococcus epidermidis 29 33 96 48 100 10 100 37 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (15 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Collection Department, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Negative Organisms, Pediatric Inpatient Isolates Only, Non-Urine
Antimicrobial susceptibility of frequently encountered Gram-negative aerobic bacteria recovered from pediatric inpatient unit specimens (excluding urines and respiratory specimens from Cystic Fibrosis patients)
submitted to the University of North Carolina Health Care Microbiology Laboratory between 4/22/2016 and 12/31/2017 for staphylococcal isolates and all other Gram negative isolates. Results are expressed as percent of
strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are included only if more than 30 isolates
were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
ER
TA
PE
NE
M
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
ME
RO
PE
NE
M
MIN
OC
YC
LIN
E
PIP
ER
AC
ILL
IN +
TA
ZO
BA
CT
AM
TO
BR
AM
YC
IN
S S S S S S S S S S S S S S S
Escherichia coli 21 90 14 52 19 90 90 100 81 90 100 90 86
Klebsiella pneumoniae 16 100 94 81 100 100 100 100 100 100 94 100
Pseudomonas aeruginosa 44 89 95 98 84 84 77 93 95 93
Serratia marcescens 15 100 100 93 100 100 100 100 87 87
Stenotrophomonas maltophilia 16 43 81 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (15 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Collection Department, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For Inpatient Cultures
Gram Negative Organisms, Pediatric Inpatient Urine Isolates Only
Antimicrobial susceptibility of frequently encountered Gram-negative aerobic bacteria recovered from pediatric inpatient unit* urine specimens submitted to the University of North Carolina Health Care Microbiology
Laboratory between 4/22/2016 and 12/31/2017. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains
account for the balance. Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of
isolates may not be a large enough sampling size to have statistical validity.
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AM
PIC
ILL
IN
AM
PIC
ILL
IN +
SU
LB
AC
TA
M
CE
FA
ZO
LIN
CE
FE
PIM
E
CE
FT
AZ
IDIM
E
CE
FT
RIA
XO
NE
CIP
RO
FL
OX
AC
IN
ER
TA
PE
NE
M
GE
NT
AM
ICIN
LE
VO
FL
OX
AC
IN
ME
RO
PE
NE
M
NIT
RO
FU
RA
NT
OIN
PIP
ER
AC
ILL
IN +
TA
ZO
BA
CT
AM
TO
BR
AM
YC
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
S S S S S S S S S S S S S S S S
Escherichia coli 61 34 72 33 93 84 100 85 88 100 97 87 59
Klebsiella pneumoniae 14 86 71 100 93 100 100 93 100 36 100 86
Pseudomonas aeruginosa 13 100 92 92 92 92 85 100 92 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (10 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Order Mode, Resulting Laboratory, Collection Department, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For All Cultures
Aerobic Organisms, Cystic Fibrosis Cultures
Antimicrobial susceptibility of frequently encountered aerobic bacteria recovered from CF respiratory specimens submitted to the University of North Carolina Health Care Microbiology Laboratory between 4/22/2016 and
12/31/2017, all isolates. Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance.
Susceptibility data are included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large
enough sampling size to have statistical validity.
# Organism is Intrinsically Resistant
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
AZ
TR
EO
NA
M
CE
FE
PIM
E
CE
FT
AR
OL
INE
CE
FT
AZ
IDIM
E
CIP
RO
FL
OX
AC
IN
CL
IND
AM
YC
IN
DO
XY
CY
CL
INE
ER
YT
HR
OM
YC
IN
GE
NT
AM
ICIN
IMIP
EN
EM
LE
VO
FL
OX
AC
IN
LIN
EZ
OL
ID
ME
RO
PE
NE
M
MIN
OC
YC
LIN
E
OX
AC
ILL
IN
PIP
ER
AC
ILL
IN +
TA
ZO
BA
CT
AM
TO
BR
AM
YC
IN
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN
S S S S S S S S S S S S S S S S S S S S
Burkholderia cenocepacia 18 72 28 61 50
Burkholderia multivorans 41 76 24 88 15
Methicillin resistant Staphylococcus aureus 152 100 26 93 3 97 98 96 100
Methicillin-Susceptible Staphylococcus aureus 217 100 45 92 27 91 99 100 97 100
Mucoid Pseudomonas aeruginosa 567 41 65 65 80 52 100 62 38 73 80 82
Smooth Pseudomonas aeruginosa 596 41 57 60 71 53 57 43 66 70 71
Stenotrophomonas maltophilia 136 22 49 96 63
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (15 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For All Cultures
Aerobic Streptococcus spp., All Isolates, All Ages
Antimicrobial susceptibility of Streptococcus species recovered from all specimens submitted to the University of North Carolina Hospitals Microbiology Laboratory between 4/22/2016 and 12/31/2017. Results are
expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are included only if
more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to have statistical
validity.
UNCH MCLENDON LABORATORY
TO
TA
L
CE
FT
RIA
XO
NE
CE
FT
RIA
XO
NE
CS
F
CL
IND
AM
YC
IN
ER
YT
HR
OM
YC
IN
LE
VO
FL
OX
AC
IN
MIN
OC
YC
LIN
E
PE
NIC
ILL
IN G
PE
NIC
ILL
IN G
CS
F
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
VA
NC
OM
YC
IN
S S S S S S S S S S
Streptococcus agalactiae (group b) 191 100 47 34 93 19 100
Streptococcus mitis group 64 96 76 22 50 38 100
Streptococcus pneumoniae 145 90 50 56 11 100 85 32 35 100
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (20 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Resulting Laboratory, Organism, Antibiotic, Susceptibility
Haemophilus influenzae, All Ages Antimicrobial susceptibility of Haemophilus influenzae recovered from all specimens submitted to the University of North Carolina Hospitals Microbiology Laboratory between 4/22/2016 and 12/31/2017. Results are expressed as percent of strains tested to be beta-lactamase positive.
TO
TAL
BET
A-L
AC
TAM
ASE
PO
SITI
VE
Haemophilus influenzae 269 28
UNCH MCLENDON LABORATORY
For All Cultures
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For All Cultures
Yeast, All Ages
Antimicrobial susceptibility of frequently encountered yeasts recovered from patient specimens submitted to the University of North Carolina Hospitals Microbiology Laboratory between 4/22/2016 and 12/31/2017. Results
are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are included
only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to have
statistical validity.
# Candida krusei is intrisically resistant to Fluconazole.
UNCH MCLENDON LABORATORY
TO
TA
L
CA
SP
OF
UN
GIN
FL
UC
ON
AZ
OL
E
MIC
AF
UN
GIN
VO
RIC
ON
AZ
OL
E
S S S S
Candida albicans 62 100 98 97 95
Candida glabrata 60 40 100
Candida krusei 10 100 100 100
Candida parapsilosis 31 100 94 100 97
Candida tropicalis 20 95 85 100 85
Indicates < 30 isolates
* Only organisms isolated and tested in significant numbers (10 or greater) are reported.Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Resulting Laboratory, Organism, Antibiotic, Susceptibility
Antibiogram UNCHCS
Microbiology
Date range: 4/22/2016 to 12/31/2017
For All Cultures
Mycobacteria, All Ages
Antimicrobial susceptibility of frequently encountered acid-fast bacilli recovered from patient specimens submitted to the University of North Carolina Hospitals Microbiology Laboratory between 4/22/2016 and 12/31/2017.
Results are expressed as percent of strains tested to be susceptible by in vitro susceptibility testing. Strains yielding intermediate results together with resistant strains account for the balance. Susceptibility data are
included only if more than 30 isolates were tested unless considered significant. In cases where fewer than 30 isolates were tested for a specific drug, the number of isolates may not be a large enough sampling size to
have statistical validity.
UNCH MCLENDON LABORATORY
TO
TA
L
AM
IKA
CIN
CE
FO
XIT
IN
CL
AR
ITH
RO
MY
CIN
ET
HA
MB
UT
OL
5.0
ISO
NIA
ZID
0.1
LIN
EZ
OL
ID
MO
XIF
LO
XA
CIN
PZ
A 1
00
RIF
AM
PIN
1.0
TR
IME
TH
OP
RIM
+
SU
LF
AM
ET
HO
XA
ZO
LE
S S S S S S S S S S
Mycobacterium abscessus group 85 86 2 24 18 1 12
Mycobacterium tuberculosis complex 25 100 92 92 100
Indicates < 30 isolates
Below 60% Between 60% and 90% 90% and above
Run on: 4/23/2018 at 0319
1
For susceptibility tests verified between 4/22/2016 and 12/31/2017Grouped by Resulting LaboratoryFiltering on Resulting Laboratory, Organism, Antibiotic, Susceptibility
